|
|
Zimbabwe
|
2016/18.2/5223
|
DOLIO SABIN ONE AND THREE (ORAL)
|
POLIOMYELITIS VIRUS TYPES 1,3 (LIVE, INACTIVATED; ORAL)
|
GLAXOSMITHKLINE BIOLOGICALS S. A., PARC DELA NOIRE EPINE, RUE FLEMING 20, 1300, WAVRE, BELGIUM; GLAXOSMITHKLINE BIOLOGICALS, RUE DE L'INSTITUTE 89, B 1330 , RIXENSART, BELGIUM;
|
PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
|
Details →
|
|
|
Botswana
|
BOT1101860
|
AVAMYS NASAL SPRAY
|
Fluticasone propionate 27.5mcg
|
GLAXOSMITHKLINE BIOLOGICALS SA,
|
Registered/Compliant
|
Details →
|
|
|
Uganda
|
NDA/MAL/HDP/1557
|
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPES (1,5,6B,7F,9V,14,23F) + (4,18C,19F) + PROTEIN D+TETANUS TOXOID+DIPTHERIA TOXOID CARRIER PROTEINS AND ALUMINIUM PHOSPHATE
|
-
|
GLAXOSMITHKLINE BOILOGICALS, S.A RUE DE I'INSTITUT 89 B-1330 RIXENSART
|
Registered
|
Details →
|
|
|
Uganda
|
NDA/MAL/HDP/6832
|
MENINGOCOCCAL POLYSACCHARIDE SEROGROUPS A, C, W-135 & Y CONJUGATE VACCINE
|
-
|
1. GLAXOSMITHKLINE BIOLOGICALS RUE DE L’INSTITUT 89, 1330 RIXENSART, BELGIUM BELGIUM SCOPE:COMPLETE MANUFACTURE OF FINISHED PHARMACEUTICAL PRODUCT
|
Registered
|
Details →
|
|
|
Tanzania
|
TAN 08,160 J07A GSK
|
Cervarix Vaccine
|
3 - O - deacyl- 4- monophosphoryl lipid A 50 mcg/ml,Aluminium Hydroxide 0.5 mg,Human Papillomavirus type 16 L1 Protein 20 µg/0.5 ml,Human Papillomavirus type 18 L1 Protein 20 µg/0.5 ml
|
GlaxoSmithKline Biologicals SA
|
Registered/Compliant
|
Details →
|
|
|
Uganda
|
NDA/MAL/HDP/6810
|
HUMAN PAPILLOMA VIRUS VACCINE (RDNA)
|
-
|
GLAXOSMITHKLINE BOILOGICALS, S.A RUE DE I'INSTITUT 89 B-1330 RIXENSART
|
Registered
|
Details →
|
|
|
Tanzania
|
TZ12H240
|
Rotarix Oral Suspension Vaccine
|
Human Rotavirus Live Attenuated R1X4414 Strain CCLD50 Not Less than 10000000 CCID50/dose
|
GlaxoSmithKline Biologicals SA
|
Registered/Compliant
|
Details →
|
|
|
Tanzania
|
TZ 17 H 0106
|
Polio Sabin One and Three (Oral)
|
Virus Polio Type 1, strain LSc, 2ab > 10(6.0) CCID50/0.1ml,Virus Polio Type 3, strain Leon 12a > 10(5.8) CCID50/0.1ml
|
GlaxoSmithKline Biologicals SA
|
Registered/Compliant
|
Details →
|
|
|
Uganda
|
NDA/MAL/HDP/5124
|
DIPHTHERIA TOXOID+TETANUS TOXOID+PERTUSSIS TOXOID(PT)+FILAMENTOUS HAEMAGGLUTININ(FHA)+PERTACTIN(69KDA OMP)+HBSAG PURIFIED,INACTIVATED POLIO VIRUS TYPE I+INACTIVATED POLIO VIRUS TYPE II+INACTIVATED POLIO VIRUS TYPE III+PURIFIED CAPSULAR POLYSACCHARIDE OF HIB COVALENTLY BOUND TO TETANUS TOXOID(PRP-T)
|
-
|
GLAXOSMITHKLINE BOILOGICALS, S.A RUE DE I'INSTITUT 89 B-1330 RIXENSART
|
Registered
|
Details →
|
|
|
Tanzania
|
TZ 16 H 0230
|
Nimenrix vaccine
|
1conjugated to tetanus toxoid carrier protein 44 mcg/ml,Neisseria meningitidis group A polysaccharide1 5 mcg/ml,Neisseria meningitidis group C polysaccharide1 5 mcg/ml,Neisseria meningitidis group W-135 polysaccharide1 5 mcg/ml,Neisseria meningitidis group Y polysaccharide1 5 mcg/ml
|
GlaxoSmithKline Biologicals SA
|
Registered/Compliant
|
Details →
|
|
|
Uganda
|
NDA/MAL/HDP/11426
|
RTS,S (PLASMODIUM FALCIPARUM AND HEPATITIS B ANTIGEN )
|
-
|
GLAXOSMITHKLINE BIOLOGICALS S.A, PARC DE LA NOIRE EPINE, AVENUE FLEMING 20-1300 WAVRE - BELGIUM| GLAXOSMITHKLINE BIOLOGICALS, 637 RUE DES AULMOIS, 59230 SAINT-AMAND-LES-EAUX
|
Registered
|
Details →
|
|
|
Rwanda
|
Rwanda FDA-HBP-MA-0129
|
ROTARIX
|
Human rotavirus, live attenuated vaccine, 1 dose (1.5 ml) contains: Human rotavirus RIX4414 strain (live, attenuated) not less than 106.0 CCID50
|
GLAXOSMITHKLINE BIOLOGICALS,
|
Registered
|
Details →
|
|
|
Tanzania
|
TAN 25 V 0661
|
Rotarix
|
Di-sodium adipate 132.74 mg mg/ 1.5 ml,Dulbecco’s Modified Eagle’s Medium (DMEM) 2.26 mg mg/ 1.5 ml,Live attenuated Human Rotavirus RIX4414 Strain not less than 10^6.0 CCID50/dose,Sucrose 1.073g gram,Water for Injection q.s. ad 1.5ml ml
|
GlaxoSmithKline Biologicals SA
|
Registered/Compliant
|
Details →
|
|
|
Tanzania
|
TAN 05,645 J07A GSK
|
Engerix B
|
Hepatitis B Vaccine 10 mcg/0.5ml
|
GlaxoSmithKline Biologicals SA
|
Registered/Compliant
|
Details →
|
|
|
Tanzania
|
TAN 05,644 J07A GSK
|
Engerix B
|
Hepatitis B Vaccine 20 mcg/0.5ml
|
GlaxoSmithKline Biologicals SA
|
Registered/Compliant
|
Details →
|
|
|
Tanzania
|
TAN 05,645 J07A GSK
|
Engerix B Paediatric
|
Hepatitis B Vaccine 10 mcg/0.5ml
|
GlaxoSmithKline Biologicals SA
|
Registered/Compliant
|
Details →
|
|
|
Zambia
|
179/057
|
Synflorix Vaccine, Live Attenuated
|
-
|
GlaxoSmithKline Biologicals S.A
|
Registered/Compliant
|
Details →
|
|
|
Uganda
|
NDA/MAL/HDP/1328
|
HEPATITIS B SURFACE ANTIGEN
|
-
|
GLAXOSMITHKLINE BOILOGICALS, S.A RUE DE I'INSTITUT 89 B-1330 RIXENSART
|
Registered
|
Details →
|
|
|
Uganda
|
NDA/MAL/HDP/1769
|
HEPATITIS B SURFACE ANTIGEN
|
-
|
GLAXOSMITHKLINE BOILOGICALS, S.A RUE DE I'INSTITUT 89 B-1330 RIXENSART
|
Registered
|
Details →
|
|
|
Uganda
|
NDA/MAL/HDP/2185
|
LIVE ATTENUATED RIX4414 STRAIN OF HUMAN ROTAVIRUS OF THE G1P[8] TYPE
|
-
|
GLAXOSMITHKLINE BOILOGICALS, S.A RUE DE I'INSTITUT 89 B-1330 RIXENSART|
|
Registered
|
Details →
|